Document M4qNBKowERvdpjwD0V17vJ40M

5 DEPARTMENT OF HEALTH & HUMAN SERVICES Public Health Service Food and Drug Administration Rockville MD 20857 May 15, 2008 Samuel S. Epstein, M.D. Cancer Prevention Coalition University of Illinois at Chicago School of Public Health, MC 922 2121 West Taylor Street Room 322 Chicago, IL 60612 Dear Dr. Epstein: Your petition requesting the Food and Drug Administration, Require that all cosmetic talc products bear labels with a warning such as Frequent application of talcum powder in the female genital area substantially increase the risk of ovarian cancer, was received by this office on 05/15/2008. It was assigned docket number FDA-2008-P-03090001/CP and it was filed on 05/15/2008. Please refer to this docket number in future correspondence on this subject with the Agency. Please note that the acceptance of the petition for filing is a procedural matter in that it in no way reflects an agency decision on the substantive merits of the petition. Sincerely, Division of Dockets Management Office of Management Programs Office of Management fDfl -iloo%-P`03of